Skip to main content

Calithera Biosciences, Inc.

CALADelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001496671

Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Calithera Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CALA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders67257−8
Shares45.3M2.73M40.3M−2.22M (−5.2%)
Value$100.1M$5.96M$27.0M−$67.1M (−71.3%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Calithera Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CALA in Q4 2021
InstitutionSharesValue% of portfolio
Anson Funds Management LP641,262$427.0K0.06%
Jane Street Group, LLC100,025$67.0K0.00%
Caption Management, LLC81,628$55.0K0.00%
Susquehanna International Group, LLP46,958$31.0K0.00%
Atom Investors LP46,171$31.0K0.01%
Engineers Gate Manager LP23,424$16.0K0.00%
Two Sigma Securities, LLC18,826$13.0K0.00%
Algert Global LLC16,790$11.0K0.00%
Aquatic Capital Management LLC4,700$3.00K0.01%
Quent Capital, LLC56$00.00%

Sold out (18)

Institutions that held Calithera Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (2)

Institutions that held Calithera Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CALA in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Delphi Management Partners VIII, L.L.C.2,426,702$5.29M
Marshall Wace North America L.P.307,244$670.0K